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Abstract
Background: A decrease in HOXA11 expression in eutopic mid-secretory endometrium has been found in women
with endometriosis-associated infertility.
Methods: Using Real-time quantitative PCR (RQ-PCR) and western blotting analysis we studied the HOXA11
transcript and protein levels in mid-luteal eutopic endometrium from eighteen infertile women with minimal
endometriosis, sixteen healthy fertile women and sixteen infertile women with fallopian tubal occlusion from the
Polish population. We also evaluated transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in
these groups of women.
Results: There were significantly lower levels of HOXA11 transcripts (p = 0.003, p = 0.041) and protein (p = 0.004,
p = 0.001) in women with endometriosis as compared to fertile women and infertile women with tubal occlusion.
Moreover, we found significantly higher methylation levels of the CpG region in the first exon of HOXA11 in
infertile women with endometriosis compared with fertile women (p < 0.001) and infertile women with tubal
occlusion (p < 0.001). We also observed significantly increased levels of DNMT3A transcript in women with
endometriosis than fertile women (p = 0.044) and infertile women with tubal occlusion (p = 0.047). However, we
did not observe significant differences in DNMT1 and DNMT3B transcript levels between these investigated groups
of women.
Conclusions: We confirmed that reduced HOXA11 expression may contribute to endometriosis-associated infertility.
Moreover, we found that DNA hypermethylation can be one of the possible molecular mechanisms causing a
decrease in HOXA11 expression in the eutopic mid-secretory endometrium in infertile women with endometriosis.
Background
Endometriosis is a gynecological disease that is charac-
terized by occurrence of tissue similar to the lining of
the uterus elsewhere in the body [1,2]. Endometriosis
lesions can be located in the cavity and walls of the pel-
vis, on the ovaries, the fallopian tubes, the rectal-vaginal
septum, and other body sites [1,2]. This disease is often
accompanied by pelvic pain, inflammation and results in
infertility in 30 to 50% of the affected women [3-5].
It has been suggested that endometriosis-associated
infertility may be due to disorders of folliculogenesis,
decreased fertilization, defective implantation, and
reduced oocyte quality with low capacity of blastocyst
implantation [6,7]. Estrogen and progesterone are
responsible for the regulation of numerous genes’
expression during the follicular and luteal phases of the
menstrual cycle [8]. In women with endometriosis, pro-
gesterone is not able to induce several genes’ expression
during the window of implantation as compared to
women without endometriosis. This defective response
to progesterone may cause hostile conditions for blasto-
cyst implantation in women with endometriosis [9-11].
The occurrence of endometriosis can be linked to
some genetic factors, immunological disorders, defective
estrogen metabolism, and exposure to environmental
contamination and toxins [12-15]. However, the etio-
pathogenesis and pathophysiology of subfertility in
women with endometriosis is still elusive [2].
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accompanied by aberrant methylation and expression of
steroidogenic factor-1 (SF-1), estrogen receptor 2 (ESR2),
progesterone receptor (PR-B) and HOXA10 genes in the
eutopic endometrium of women with endometriosis
[16-19]. The deficient expression of HOXA10 and
HOXA11 in infertile women with endometriosis and in
animal models has been demonstrated [16,20-23]. How-
ever, it is still unclear whether the observed decreased
expression of the HOXA11 gene can be related to its
hypermethylation in endometriosis-associated infertility.
Therefore we studied the effect of DNA regulatory
sequences’ methylation on the HOXA11 transcript and
protein levels in eighteen infertile women with minimal
endometriosis, sixteen fertile women and sixteen infer-
tile women with fallopian tubal occlusion from a Polish
cohort. In these groups of women, we also evaluated
transcript levels of DNA methyltransferases DNMT1,
DNMT3A and DNMT3B.
Methods
Patients and controls
Since advanced endometriosis may lead to anatomical
distortions and adhesions resulting in infertility, we
focused our study on infertility associated with minimal
endometriosis. Data for women with infertility-asso-
ciated endometriosis, fertile women and infertile patients
with fallopian tubal occlusion were randomly collected
in the Gynecologic and Obstetrical University Hospital,
Division of Reproduction in Poznan, Poland (Table 1).
Women with endometriosis and fertile women were
examined for the cause of infertility, suspected pelvic
endometriosis, or chronic pelvic pain. Then they were
divided into eighteen infertile women with minimal
endometriosis and sixteen fertile women. Minimal endo-
metriosis in infertile women was diagnosed based on
visualization of endometriotic lesions and histopatholo-
gic criteria (Table 1). The stage of endometriosis was
evaluated according to the revised classification of the
American Society for Reproductive Medicine [24]. The
studied women with endometriosis displayed no anato-
mical changes in the reproductive tract. The women
with endometriosis and with fallopian tubal occlusion
exhibited regular menses and a minimum 1 year of
infertility with a current desire for conception, and no
contribution of male factor infertility. The fertile women
assigned to the control group exhibited chronic pelvic
pain without any pelvic abnormalities determined by
laparoscopy. The fertile women were diagnosed as hav-
ing varicose veins in the pelvic floor but no signs of past
or present inflammation. These fertile women had at
least one child born no later than 2 years before laparo-
scopy, regular menses, and no anatomical changes in
the reproductive tract (Table 1). The second control
group included the women with fallopian tubal occlu-
sion diagnosed based on hysterosalpingography and sub-
sequently verified by methyl blue administration to
fallopian tubes during laparoscopy [25]. Furthermore,
hysteroscopy and pipelle biopsy from women with endo-
metriosis, and fertile women and infertile women with
tubal occlusion were respectively employed for histo-
pathologic evaluation to exclude individuals with patho-
logical endometrium. All participating individuals had
not used oral contraception, hormonal therapy, or an
intrauterine device for half a year prior to the endome-
trial biopsy. Fertile women and infertile women with
tubal occlusion were matched by age to the patients
with endometriosis and all individuals were Caucasian
from the same region of Poland (Table 1). Written
informed agreement was obtained from all participating
individuals. The procedures of the study were approved
by the Local Ethical Committee of Poznań University of
Medical Sciences. All biopsy specimens were collected
during the middle secretory phase based on the endo-
metrial dating criteria of Noyes et al. [26]. Sample of
eutopic endometrial tissue from patients and controls
was respectively obtained by pipelle or hysteroscopic
biopsy during the implantation window, i.e. 7-9 days
after ultrasound-confirmed ovulation. The eutopic endo-
metrium samples were then used for total RNA, protein,
and DNA isolation.
Antibodies
Goat polyclonal (Gp) anti-HOXA11 antibodies (Ab) (C-
16, 200 μg/1.0 ml), donkey anti-goat horseradish peroxi-
dase (HRP)-conjugated Ab (200 μg/0.5 ml), and anti-
Table 1 Clinical characteristics of infertile women with minimal endometriosis, fertile women and infertile women with
tubal occlusion.
Characteristics Endometriosis Fertile women Tubal occlusion
Number of patients 18 16 16
Age (years) 31 (24-38)
a 31 (25-37)
a 32 (25-39)
a
Parity NA 2 (1-3)
a NA
Duration of infertility (Years) 3 (1-4) NA 3 (1-4)
rASRM stage
b Stage I (n = 8)
Stage II (n = 10)
NA NA
Median (Range)
a, revised American Society for Reproductive Medicine classification (rASRM)
b [24], NA-not applicable.
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were provided by Santa Cruz Biotechnology (Santa
Cruz, CA).
Real-time quantitative PCR (RQ-PCR) analysis of HOXA11
and DNA methyltransferase transcript levels
Total RNA was isolated by RNeasy Protect Mini Kit
Qiagen (Hilden, Germany). RNA samples were treated
with DNase I from DNase Set Qiagen (Hilden, Ger-
many) and quantified. A volume of 0.5 μgR N Aw a s
reverse-transcribed intoc D N Au s i n gQ u a n t i T e c t
Reverse Transcription Kit and oligo-dT primers from
Qiagen (Hilden, Germany). The efficiency of reverse
transcription was controlled by a series of RNA dilu-
tion-reverse-transcribed and comparison of RQ-PCR Ct
differences for cDNA samples [27].
RQ-PCR was conducted in a Corbett Research Rotor-
Gene 3000 thermocycler (Mortlake, Australia). Target
cDNA was quantified using relative quantification
method employing a calibrator. The calibrator was pre-
pared as a cDNA mix from all patients and control sam-
ples and consecutive dilutions were used to create a
standard curve as provided in Relative Quantification
Manual Roche Diagnostics GmbH (Mannheim, Ger-
many). The quantity of HOXA11, DNMT1, DNMT3A
and DNMT3B transcript in each sample was standar-
dized by human glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) and b-actin (ACTB) transcript levels.
For amplification, 60 ng cDNA solution was added to
18 μl (total 20 μl) of DyNAmo HS SYBR
® Green qPCR
Kit from Finnzymes (Espoo, Finland) and primers (Addi-
tional file 1, Table S1). One RNA sample of each pre-
paration was processed without the reverse transcription
(RT)-reaction to provide a negative control in subse-
quent PCR. The quantity of HOXA11 transcripts in
each sample was standardized by GAPDH and ACTB
cDNA. Each sample was determined in triplicate and
the HOXA11, DNMT1, DNMT3A and DNMT3B
mRNA levels were expressed as the multiplicity of these
cDNA concentrations in the calibrator.
Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and western blot analysis
Tissue samples were minced in liquid nitrogen followed
by lysis in RIPA buffer. Next, 30 μg of protein were resus-
pended in sample buffer and separated on 12% Tris-gly-
cine gel using the SDS-PAGE system. Gel proteins were
transferred to PVDF membrane, which was blocked with
5% milk in Tris-buffered saline/Tween. Immunodetection
was performed with Gp anti-HOXA11 Ab (C-16, 1:500
dilution, 4.0 μg) followed by incubation with donkey
anti-goat horseradish peroxidase (HRP)-conjugated Ab
(1:3000 dilution, 1.3 μg). The membranes were then
stripped and incubated with anti-b-actin HRP-conjugated
Ab (clone I-19, 1:3000 dilution, 0.66 μg) to ensure equal
protein loading of the lanes. Bands were revealed using
ECL kit and Hyperfilm ECL Amersham (Piscataway, NJ).
The quantities of western blot-detected HOXA11 and b-
actin proteins were determined based on the band optical
density. The band densitometry readings were normal-
ized to b-actin loading control to calculate the HOXA11-
to-b-actin optical density ratio.
Sodium bisulfite DNA sequencing of cytosine-guanine
dinucleotide (CpG) rich regions of the HOXA11 gene
Genomic DNA was isolated by the salting out method
[28], and DNA cytosine bases were converted to uracil
using the EZ DNA Methylation Kit™ procedure from
Zymo Research Corporation (Orange, CA). The loca-
tions of CpG island in regions I, II, and III of the
HOXA11 gene (Additional file 2, Figure S1) was deter-
mined based on two online programs [29,30].
The HOXA11 regions I, II, and III were amplified from
the bisulfite-modified DNA by the three pairs of primers
complementary to the bisulfite-DNA modified sequence
(Additional files 1, Table S1; Additional file 2, Figure S1).
PCR amplification was conducted by FastStart Taq DNA
Polymerase from Roche Diagnostic GmbH (Mannheim,
Germany). The PCR products were purified using Agarose
Gel DNA Extraction Kit Roche (Mannheim, Germany)
with subsequent cloning into pGEM-T Easy Vector Sys-
tem I Promega (Madison, WI) and transformation into
TOPO10 E. coli strain cells. Plasmid DNA isolated from
ten positive bacterial clones was used for commercial
sequencing of the cloned fragment of DNA. The results of
bisulphite sequencing were assessed and presented using
BiQ analyzer software [31] and BDPC web server [32].
Statistical analysis
Statistical analysis was conducted by Systat Software Inc
(2006). SIGMASTAT (data analysis software system)
version 3.5 [33]. Data groups were analyzed by Mann-
Whitney Rank Test to evaluate if there was significance
(P < 0.05) between the groups.
Results
Levels of HOXA11 transcript and protein in infertile
women with endometriosis, fertile women and infertile
women with tubal occlusion
We used RQ-PCR and western blotting analysis to eval-
uate HOXA11 transcript and protein levels, respectively,
in eutopic mid-secretory endometrium from infertile
women with endometriosis, fertile women and women
with tubal occlusion. We observed significantly lower
levels of HOXA11 transcript in women with endome-
triosis as compared to fertile women (p = 0.003) and
women with tubal occlusion (p = 0.041) (Table 2, Figure
1A). We also found significantly reduced HOXA11
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women with endometriosis than in fertile women (p =
0.004) and women with tubal occlusion (p = 0.001)
(Table 2, Figures 1B and 1C).
DNMT1, DNMT3A and DNMT3B transcript levels in
infertile women with endometriosis, fertile women and
infertile women with tubal occlusion
RQ-PCR analysis showed significantly increased levels of
DNMT3A transcript in eutopic mid-secretory endome-
trium from women with endometriosis compared to fer-
tile women (p = 0.044) and women with tubal occlusion
(p = 0.047) (Table 3 and Figure 2A). However, we did
not observe significant differences in DNMT1 (p =
0.621, p = 0.470) and DNMT3B (p = 0.717, p = 0.100)
transcript levels between the investigated groups (Table
3 and Figures 2B and 2C).
DNA methylation levels of HOXA11 CpG rich regions in
eutopic mid-luteal endometrium from infertile women
with endometriosis, fertile women and infertile women
with tubal occlusion
W ep e r f o r m e ds o d i u mb i s u l f i t eD N As e q u e n c i n go f
HOXA11 regions I, II, and III (Additional file 2, Figure
Table 2 HOXA11 transcript and protein levels in eutopic mid-luteal endometrium from infertile women with
endometriosis, fertile women and infertile women with tubal occlusion
Endometriosis Fertile women p
c Tubal occlusion p
d
Median (Range) Mean (± SD) Median (Range) Mean (± SD) Median (Range) Mean (± SD)
0.125 (0.0252- 0.469)
a 0.155 ± 0.118
a 0.246 (0.101- 8.669)
a 1.449 ± 2.608
a 0.003 0.322 (0.035- 7.266)
a 0.922 ± 1.710
a 0.041
0.694 (0.316- 3.772)
b 1.023 ± 0.873
b 1.385 (0.753-4.312)
b 1.608 ± 0.889
b 0.004 1.994 (0.837 - 5.859)
b 1.570 ± 0.821
b 0.001
a The target mRNA levels were corrected to the amount of ACTB and GAPDH cDNA and expressed as multiplicity of these cDNA copies in the calibrator.
bThe
amount of Western blot-detected proteins was presented as the HOXA11-to-b-actin protein band optical density ratio. P values for
cendometriosis vs fertile
women or
dendometriosis vs infertile women with tubal occlusion were assed by Mann-Whitney Rank Sum Test.
Figure 1 HOXA11 transcript (A) and protein (B) levels and representative picture of western blot analysis of HOXA11 protein contents
(C) in eutopic mid-luteal endometrium from infertile women with endometriosis, fertile women and infertile women with tubal
occlusion. The eutopic endometrium tissue from women with endometriosis, fertile women and infertile women with tubal occlusion was
respectively obtained by pipelle or hysteroscopic biopsy during the implantation window, followed by total RNA and protein isolation. RNA was
reverse-transcribed and HOXA11 cDNAs were investigated by RQ-PCR relative quantification analysis. To normalize the quantity of transcripts in
each sample, HOXA11 mRNA levels were normalised to the amount of GAPDH and ACTB cDNA. The amounts of HOXA11 mRNA were expressed
as the multiplicity of these cDNA copies in the calibrator. For western blot analysis, proteins were separated by SDS-PAGE and transferred to a
PVDF membrane. This membrane was then incubated with Gp anti-HOXA11 Ab, followed by incubation with anti-goat HRP-conjugated Ab. To
ensure equal protein loading of the lanes, the membranes were also incubated with anti-actin HRP-conjugated Ab. The amount of western blot-
detected HOXA11 proteins was presented as the HOXA11-to-b-actin band optical density ratio. The boxes and the middle lines correspond to
the values from the lower to upper quartiles and medians, respectively.
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regions I and III in all infertile women with endometrio-
sis and all fertile women and women with tubal occlu-
s i o n .H o w e v e r ,w ef o u n ds i g n i f i c a n t l yh i g h e r
methylation levels of HOXA11 region in II the in euto-
pic mid-secretory endometrium obtained from infertile
women with endometriosis as compared to material
obtained from the fertile women (p < 0.001) and women
with tubal occlusion (p < 0.001) (Figure 3). In the group
of eighteen infertile women with endometriosis, we
found fifteen (83.3%) individuals with methylation in
HOXA11 region II (Figure 3). By contrast, in both fertile
w o m e na n dw o m e nw i t ht u b a lo c c l u s i o nw ef o u n do n e
(6.2%) subject with DNA methylation in HOXA11 region
II (Figure 3).
Discussion
Hoxa11 belongs to the Hox gene family, which are genes
that encode transcription factors expressed throughout
embryonic development [34]. An equivalent of Hoxa11
has been found in the murine model as the Abdominal-
B-type homeobox gene expressed in the limbs, kidney
and stromal cells surrounding the Mullerian and Wolf-
fian ducts [35]. Continued expression of hox genes has
also been found in the female reproductive tract [36,37].
Mice that have either either Hoxa11 or Hoxa10 gene
deletion are sterile, suggesting that these genes’ products
play an elementary role in endometrial growth, differen-
tiation, receptivity, embryonic development, and female
fertility [36,37].
Previously, we reaffirmed that DNA hypermethylation
can be one of the mechanisms silencing HOXA10
expression in the mid-secretory endometrium in infertile
women with endometriosis [38]. We subsequently
decided to extend this study for HOXA11 in these
patients.
In present study we confirmed that both HOXA11
mRNA and protein levels were significantly decreased in
eutopic mid-luteal endometrium in infertile women with
endometriosis as compared to fertile women. However,
there were no correlations between HOXA11 transcript
and protein levels to age, disease duration, and clinical
characteristics of patients with endometriosis (results
not shown).
HOXA10 and HOXA11 have displayed significant up-
regulation in endometrial glands and stroma in humans
during the mid-luteal phase at the period of implanta-
tion [39,40]. By contrast, women with endometriosis did
not demonstrate an increase in the expression of these
genes throughout the window of implantation [20,21].
The reduced expression of HOXA11 along with
HOXA10 in the endometrium has been reported by Tay-
lor et al. (1999), who suggested that this may result in
infertility in patients with endometriosis [21]. Recently,
Rackow et al. (2011) demonstrated a marked decrease
in HOXA11 and HOXA10 mRNA levels in women with
endometrial polyps with reduced pregnancy rates [41].
Our bisulfite DNA sequencing of HOXA11 CpG rich
region II (Additional file 2, Figure S1) showed signifi-
cantly increased levels of DNA methylation in eutopic
mid-secretory endometrium from infertile women with
minimal endometriosis as compared to fertile women.
However, we did not find DNA methylation in
HOXA11 CpG rich regions I and III in the same
patients. Differential methylation in these regions
might be due to distinct histone modifications and/or
distinct interactions of nuclear proteins and non-cod-
ing RNAs to various chromatin conformations. These
events might modulate DNA methyltransferase
(DNMTs) accessibility to DNA, resulting in differen-
tially methylated gene regions [42].
The hypermethylation of HOXA10 DNA regulatory
sequences have been well documented to date in
humans, and in murine and baboon endometriosis
[16,22,43]. However, little is know about effect of
HOXA11 gene methylation on its expression in infertile
women with endometriosis. Recently, it has been
demonstrated that HOXA11 DNA methylation is signifi-
cantly associated with residual tumors after cytoreduc-
tive surgery and is a marker independently associated
with poor outcome in ovarian cancer [44].
In humans, three CpG islands in the HOXA11 gene
w e r el o c a l i z e d :t h ef i r s ti s2 4 0 8b pu p s t r e a mo fe x o n1 ,
t h es e c o n di sm a i n l yi ne x o n1 ,a n dt h et h i r di si nt h e
intron separating exons 1 and 2. (Additional file 2, Fig-
ure S1). The methylation of mammalian genomic DNA
is carried out by DNMTs [45]. The role of some
DNMTs in silencing HOXA gene transcription in
Table 3 DNMT1, DNMT3A and DNMT3B transcripts in eutopic mid-luteal endometrium from infertile women with
endometriosis, fertile women and infertile women with tubal occlusion.
Gene Endometriosis Fertile women p
a Tubal occlusion p
b
Median (Range) Mean (± SD) Median (Range) Mean (± SD) Median (Range) Mean (± SD)
DNMT1 0.015(0.075 - 0.003) 0.094 ± 0.216 0.017(0.047- 0.003) 0.018 ± 0.013 0.621 0.015(0.071 - 0.001) 0.026 ± 0.025 0.470
DNMT3A 0.182(0.590 - 0.016) 0.203 ± 0.173 0.066(0.196- 0.017) 0.07 ± 0.052 0.044 0.042(0.508 - 0.002) 0.118 ± 0.173 0.047
DNMT3B 0.005(0.036 - 0.001) 0.014 ± 0.014 0.013(0.058- 0.002) 0.016 ± 0.016 0.717 0.019(0.1 - 0.001) 0.034 ± 0.034 0.100
The target mRNA levels were corrected to the amount of ACTB and cDNA and expressed as multiplicity of these cDNA copies in the calibrator. P values for
aendometriosis vs fertile women or
bendometriosis vs infertile women with tubal occlusion were assed by Mann-Whitney Rank Sum Test.
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Page 5 of 8Figure 2 DNMT1 (A), DNMT3A (B) and DNMT3B (C) transcript levels in eutopic mid-luteal endometrium from infertile women with
endometriosis, fertile women and infertile women with tubal occlusion. The eutopic endometrial tissue from women with endometriosis,
fertile women and infertile women with tubal occlusion was respectively obtained by pipelle or hysteroscopic biopsy during the implantation
window, followed by total RNA isolation. RNA was reverse-transcribed and DNMT1, DNMT3A and DNMT3B cDNAs were investigated by RQ-PCR
relative quantification analysis. To normalize the quantity of transcripts in each sample, DNMTs mRNA levels were normalised to the amount of
GAPDH and ACTB cDNA. The amounts of DNMTs mRNA were expressed as the multiplicity of these cDNA copies in the calibrator. The boxes
and the middle lines correspond to the values from the lower to upper quartiles and medians, respectively.
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been reported [46]. We observed markedly increased
levels of DNMT3A transcript in eutopic mid-secretory
endometrium from women with endometriosis com-
pared to fertile women. Our observations were on par
with Wu et al. (2007), who also found significantly
higher levels of DNMT3A in eutopic endometrium from
infertile women with endometriosis as compared to con-
trols [46].
Endometriosis has been considered as an epigenetic
disease. Hypomethylation of SF-1 and ESR2 promoters
may be responsible for increased estrogen action in
women with endometriosis [18,19]. By contrast, a loss of
progesterone response in women with endometriosis
may be associated with hypermethylation of the PR-B
promoter and a reduction in this receptor’si s o f o r m
levels in endometrial tissue [17]. Moreover, hypermethy-
lation of HOXA10 causes its reduced expression, accom-
panied with some defects in blastocyst implantation in
mid-luteal endometrium [16].
We observed that decreased HOXA11 expression was
associated with hypermethylation of HOXA11 CpG rich
regions in eutopic mid-secretory endometrium from
infertile women with endometriosis compared to fertile
women. Our findings may support a view of endome-
triosis as an epigenetic disease.
HOXA11 protein alone is a repressor of the decidual
prolactin promoter, but combined with FOXO1A tran-
scription factor induces transcription of decidual prolac-
tin [47]. Therefore, HOXA11 expression may control the
proper production of decidual prolactin, which is essen-
tial for implantation and pregnancy [48]. This may indi-
cate that changes in HOXA11 expression in eutopic
endometrium throughout the implantation window can
be one of the possible molecular mechanisms of endo-
metriosis-associated infertility in women.
Additional material
Additional file 1: Supplemental Table S1. Primer sequences used for
RQ-PCR analysis and bisulfite sequencing of HOXA11 regions I, II, and III.
Additional file 2: Supplemental Figure S1. Location of CpG-rich
regions I, II, and III in the human HOXA11 gene.
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